Prenatal Genetic Diagnosis through Chorionic Villus Sampling

Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment: Sixth Edition

Volumn , Issue , 2010, Pages 160-193

  Monni, Giovanni ^a   Ibba, Rosa Maria ^b   Zoppi, Maria Angelica ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

Author keywords

American College of Obstetricians and Gynecologists (ACOG) and practice bulletin; Chorionic villus sampling (CVS) invasive techniques in prenatal diagnosis; Chorionic villus sampling under direct ultrasound guidance vagina and cervix; CVS, technical problems inherent to sampling method and diagnostic problems; Cytogenetically ambiguous results MCC or chromosome mosaicism after CVS; First trimester TA CVS versus second trimester amniocentesis; Prenatal genetic diagnosis through chorionic villus sampling; Transabdominal approach using double or single needle technique; Transabdominal chorionic villus sampling retroflexed uterus with complete posterior placenta

Indexed keywords

EID: 82355172420     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444314342.ch5     Document Type: Chapter

References (156)

1. Brambati B, Tului L. Prenatal genetic diagnosis through chorionic villous sampling. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention and treatment, 5th edn. Baltimore, MD:Johns Hopkins University Press, 2004: 179.
2. Wapner RJ, Evans MI, Davis G, et al. Procedural risks versus theology: chorionic villus sampling for Orthodox Jews at less than 8 weeks'gestation. Am J Obstet Gynecol 2002;186:1133.
3. Cates W Jr, Grimes DA. Morbidity and mortality of abortion in the United States. In: Hodgson JE, ed. Abortion and sterilization: medical and social aspects. London: Academic Press Inc, 1981: 155.
4. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004;103:729.
5. Nimkarn S, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia. Pediatr Endocrinol Rev 2006;4:99.
6. Mohr J. Foetal genetic diagnosis: development of techniques for early sampling of foetal cells. Acta Pathol Microbiol Scand 1968; 73: 73.
7. Kullander S, Sandahl B. Fetal chromosome analysis after transcervical placental biopsies during early pregnancy. Acta Obstet Gynaecol Scand 1973;52:355.
8. Hahnemann N. Early prenatal diagnosis: a study of biopsy techniques and cell culturing from extra-embryonic membrane. Clin Genet 1974; 6: 294.
9. Tietung Hospital of Anshan Iron and Steel Company. Fetal sex prediction by sex chromatin of chorionic villi cells during early pregnancy. Chin Med J 1975;1:117.
10. Kazy Z, Rozovsky IS, Bakharev VA. Chorionic biopsy in early pregnancy. A method of early prenatal diagnosis for inherited disorders. Prenat Diagn 1982; 2: 39.
11. Niazi M, Coleman DV, Loeffler FE. Trophoblast sampling in early pregnancy. Culture of rapidly dividing cells from immature placental villi. Br J Obstet Gynaecol 1981;88:1081.
12. Old JM, Ward RH, Petrou M, et al. First-trimester fetal diagnosis for haemoglobinopathies: three cases. Lancet 1982;2:1413.
13. Ward RH, Model B, Petrou M, et al. Method of sampling chorionic villi in first trimester of pregnancy under guidance of real time ultrasound. BMJ 1983 ; 286:1542.
14. Brambati B, Oldrini A, Aladerun SA. Transcervical specimen of chorionic villi in the 1st trimester of pregnancy. Pathologica 1983;75:179.
15. Dumez Y, Goossens M, Poenaru L, et al. Biopsy of chorionic villi by forceps under ultrasonic control: technic and results. J Genet Hum 1984; 32: 335.
16. Simoni G, Brambati B, Danesino C, et al. Efficient direct chromosome analysis and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet 1983; 63: 349.
17. Smidt-Jensen S, Hahnemann N. Transabdominal fine needle biopsy from chorionic villi in the first trimester. Prenat Diagn 1984;4:163.
18. Pandya PP, Brizot ML, Kuhn P, et al. First-trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol 1994;84:420.
19. Cicero S, Bindra R, Rembouskos G, et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003;23:306.
20. Monni G, Zoppi MA, Ibba RM, et al. Fetal nuchal translucency test for Down's syndrome. Lancet 1997;350:1631.
21. Monni G, Zoppi MA, Ibba RM. Absence of nasal bone and detection of trisomy 21. Lancet 2002;359:1343.
22. Zoppi MA, Putzolu M, Ibba RM, et al. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002;17:52.
23. Faiola S, Tsoi E, Huggon IC, et al. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005;26:22.
24. Nicolaides KH, Bindra R, Heath V, et al. One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation. J Matern Fetal Neonatal Med 2002;12:9.
25. Zoppi MA, Ibba RM, Putzolu M, et al. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 2001;97:916.
26. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. ACOG Committee on Practice Bulletins. Obstet Gynecol 2007;109:217.
27. Cao A. 1993 William Allan award address. Am J Hum Genet 1994;54:397.
28. Cao A, Rosatelli MC, Monni G, et al. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002;29:305.
29. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45.
30. Nagaishi M, Yamamoto T, Iinuma K, et al. Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan. J Obstet Gynaecol Res 2004;30:237.
31. Orofino MG, Argiolu F, Sanna MA, et al. Fetal HLA typing in beta thalassaemia: implications for haemopoietic stem-cell transplantation. Lancet 2003;362:41.
32. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995;33:2881.
33. Kustermann A, Zoppini C, Tassis B, et al. Prenatal diagnosis of congenital varicella infection. Prenat Diagn 1996;16:71.
34. Dong ZW, Zhou SY, Li Y, et al. Detection of a human parvovirus intrauterine infection with the polymerase chain reaction. J Reprod Med 2000;45:410.
35. Milunsky A, Milunsky JM. Genetic counseling: preconception, prenatal and perinatal. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention and treatment, 5th edn. Baltimore, MD:Johns Hopkins University Press, 2004: 1.
36. Sharma G, McCullough LB, Chervenak FA. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing. Am J Med Genet C Semin Med Genet 2007;145:99.
37. Alfirevic Z, von Dadelszen P. Instruments for chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003;1:CD000114.
38. Monni G, Ibba RM, Olla G, et al. Chorionic villus sampling by rigid forceps: experience with 300 cases at risk for thalassemia major. Am J Obstet Gynecol 1987;156:912.
39. Sidransky E, Black SH, Soenksen DM, et al. Transvaginal chorionic villus sampling. Prenat Diagn 1990 ; 10:583.
40. Monni G, Ibba RM, Lai R, et al. Transabdominal chorionic villus sampling: fetal loss rate in relation to maternal and gestational age. Prenat Diagn 1992 ; 12:815.
41. Monni G, Ibba RM, Lai R, et al. Early transabdominal chorionic villus sampling for couples at high genetic risk. Am J Obstet Gynecol 1993;168:170.
42. Brambati B, Oldrini A, Lanzani A. Transabdominal chorionic villus sampling: a freehand ultrasound guided technique. Am J Obstet Gynecol 1987;157:134.
43. Brambati B, Lanzani A, Oldrini A. Transabdominal chorionic villus sampling. Clinical experience of 1159 cases. Prenat Diagn 1988;8:609.
44. Vandenbossche F, Horovitz J, Guyon F, et al. Pain experience during chorionic villus sampling and amniocentesis: a preliminary study. Eur J Obstet Gynecol Reprod Biol 2008; 136: 189.
45. van Schoubroeck D, Verhaeghe J. Does local anesthesia at mid-trimester amniocentesis decrease pain experience? A randomized trial in 220 patients. Ultrasound Obstet Gynecol 2002;16:536.
46. Kanhai HH, Gravenhorst JB, van't Veer MB, et al. Chorionic biopsy in management of severe rhesus isoimmunisation. Lancet 1984;2:157.
47. American College of Obstetricians and Gyneco logists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol 2001;97:1.
48. Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Blood 2005;105:3382.
49. Grosheide PM, Quartero HW, Schalm SW, et al. Early invasive prenatal diagnosis in HBsAg-positive women. Prenat Diagn 1994;14:553.
50. Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005;193:437.
51. Thiede HA, Creasman WT, Metcalfe S. Antenatal analysis of the human chromosomes. Am J Obstet Gynecol 1966;94:589.
52. Simoni G, Brambati B, Danesino C, et al. Diagnostic application of first trimester trophoblast sampling in 100 pregnancies. Hum Genet 1984;66:252.
53. Associazione Italiana di Citogenetica Medica (AICM). Diagnostica Citogenetica. Consensus. 1995.Analysis 1995;8:12-42.
54. Evans MI, Ebrahim SA, Berry SM, et al. Fluorescent in situ hybridization utilization for high-risk prenatal diagnosis: a trade-off among speed, expense, and inherent limitations of chromosome-specific probes. Am J Obstet Gynecol 1994;171:1055.
55. d'Alton ME, Malone FD, Chelmow D, et al. Defining the role of fluorescence in situ hybridisation for prenatal diagnosis of aneuploidies. Am J Obstet Gynecol 1997;176:769.
56. Pertl B, Kopp S, Kroisel PM, et al. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet 1999;36:300.
57. Cirigliano V, Ejarque M, Cañadas MP, et al. Clinical application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidies. Mol Hum Reprod 2001; 7: 1001.
58. Hultén MA, Dhanjal S, Pertl B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction 2003;126:279.
59. Nicolini U, Lalatta F, Natacci F, et al. The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration. Hum Reprod Update 2004 ; 10:541.
60. Lee JA, Cheung SW, Ward PA, et al. Prenatal diagnosis of PLP1 copy number by array comparative genomic hybridization. Prenat Diagn 2005; 25: 1188.
61. van den Veyver IB, Beaudet AL. Comparative genomic hybridization and prenatal diagnosis. Curr Opin Obstet Gynecol 2006;18:185.
62. Castellvi-Bel S, Mila M, Soler A, et al. Prenatal diagnosis of fragile X syndrome: (CGG)n expansion and methylation of chorionic villus samples. Prenat Diagn 1995;15 (9): 801.
63. Willemsen R, Bontekoe CJ, Severijen LA, et al. Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum Genet 2002; 110(6): 601.
64. Rosatelli C, Falchi AM, Tuveri T, et al. Prenatal diagnosis of β-thalassemia with the synthetic oligomer technique. Lancet 1985;2:241.
65. Saiki RK, Bugawan TL, Horn GT, et al. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163.
66. Parinov S, Barsky V, Yershov G, et al. DNA sequencing by hybridization to microchip octa-and decanucleotides extended by stacked pentanucleotides. Nucleic Acids Res 1996;24:2998.
67. Foglieni B, Cremonesi L, Travi M, et al. Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. Clin Chem 2004; 50: 73.
68. Milunsky A, Littlefield JW. The prenatal diagnosis of inborn errors of metabolism. Ann Rev Med 1972; 23: 57.
69. World Health Organization Regional Office for Europe (WHO/EURO). Risk evaluation of chorionic villus sampling (CVS): report on a meeting. Copenhagen : WHO/EURO, 1992.
70. European Study Group on Prenatal Diagnosis. Methods of prenatal diagnosis. Recommendation and protocols for prenatal diagnosis. Prenat Neonatal Med 1999;4:186-201.
71. Societ à Italiana di Ecografia Ostetrica e Ginecologica (SIEOG). Diagnosi prenatale invasiva. In: Linee Guida SIEOG. Bologna:Editeam Gruppo Editoriale, 2002:45.
72. Nicolaides KH, Soothill PW, Rodeck CH, et al. Why confine chorionic villus (placental) biopsy to the first trimester? Lancet 1986;1:543.
73. Holzgreve W, Miny P, Basaran S, et al. Safety of placental biopsy in the second and third trimesters. N Engl J Med 1987;317:1159.
74. Monni G, Ibba RM, Olla G, et al. Prenatal diagnosis of β-thalassemia by second trimester chorionic villus sampling. Prenat Diagn 1988;8:447.
75. Podobnik M, Ciglar S, Singer Z, et al. Transabdominal chorionic villus sampling in the second and third trimesters of high-risk pregnancies. Prenat Diagn 1997;17:125.
76. Holzgreve W, Miny P, Schloo R. " Late CVS " international registry compilation of data from 24 centres. Prenat Diagn 1990;10:159.
77. Brandenburg H, Gho CG, Jahoda MGJ, et al. Effect of chorionic villus sampling on utilization of prenatal diagnosis in women of advanced maternal age. Clin Genet 1992;41:239.
78. Monni G, Zoppi MA, Axiana C, et al. Changes in the approach for invasive prenatal diagnosis in 35,127 cases at a single center from 1977 to 2004. Fetal Diagn Ther 2006; 21: 348.
79. Cao A, Cossu P, Monni G, et al. Chorionic villus sampling and acceptance rate of prenatal diagnosis. Prenat Diagn 1987;7:531.
80. Monni G, Olla G, Cao A, et al. Patient's choice between transcervical and transabdominal chorionic villus sampling. Lancet 1988;1:1057
81. Spencer JW, Cox DN. A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy. Obstet Gynecol 1988;72:714.
82. Dolkart L, Harter M, Snyder M. Four-dimensional ultrasonographic guidance for invasive obstetric procedures. J Ultrasound Med 2005; 24: 1261.
83. Kim SR, Won HS, Lee PR, et al. Four-dimensional ultrasound guidance of prenatal invasive procedures. Ultrasound Obstet Gynecol 2005;26:663.
84. Wijnberger LD, van der Schouw YT, Christiaens GC. Learning in medicine: chorionic villus sampling. Prenat Diagn 2000;20:241.
85. Chueh JT, Goldberg JD, Wohlferd MM, et al. Comparison of transcervical and transabdominal chorionic villus sampling loss rates in nine thousand cases from a single center. Am J Obstet Gynecol 1995;173:1277.
86. Saura R, Gauthier B, Taine L, et al. Operator experience and fetal loss rate in transabdominal CVS. Prenat Diagn 1994;14:70.
87. Nizard J, Duyme M, Ville Y. Teaching ultrasound-guided invasive procedures in fetal medicine: learning curves with and without an electronic guidance system. Ultrasound Obstet Gynecol 2002;19:274.
88. Evans MI. Teaching new procedures (editorial). Ultrasound Obstet Gynecol 2002;19:436.
89. Jenkins TM, Sciscione AC, Wapner RJ, et al. Training in chorionic villus sampling: limited experience for US fellows. Am J Obstet Gynecol 2004;191:1288.
90. Monni G, Rosatelli C, Falchi AM, et al. First trimester diagnosis of β-thalassemia in a twin pregnancy. Prenat Diagn 1986;6:63.
91. Pergament E, Schulman J, Copeland K, et al. The risk and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn 1992; 12: 377.
92. de Catte L, Liebaers I, Foulon W. Outcome of twin gestations after first trimester chorionic villus sampling. Obstet Gynecol 2000;96:714.
93. Brambati B, Tului L, Guercilena S, et al. Outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy. Ultrasound Obstet Gynecol 2001;17:209.
94. Monni G, Zoppi MA, Cau G, et al. Importance of nuchal translucency measurement in multifetal pregnancy reduction. Ultrasound Obstet Gynecol 1999 ; 13:377.
95. Wapner RJ, Johnson A, Davis G. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol 1993;82:49.
96. Antsaklis A, Souka AP, Daskalakis G, et al. Second-trimester amniocentesis vs chorionic villus sampling in multiple gestations. Ultrasound Obstet Gynecol 2002;20:476.
97. van den Berg C, Braat AP, van Opstal D, et al. Amniocentesis or chorionic villus sampling in multiple gestations? Experience with 500 cases. Prenat Diagn 1999;19:234.
98. Brambati B, Tului L, Camurri L, et al. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling. Am J Obstet Gynecol 2004;191:2035.
99. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol 2007; 165: 1380.
100. Wilson RD, Kendrick V, Wittmann BK, et al. Spontaneous abortion and pregnancy outcome after normal first-trimester ultrasound examination. Obstet Gynecol 1986;67:352.
101. Modell B. Chorionic villus sampling. Evaluating safety and efficacy. Lancet 1985;1:737.
102. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989;320:609.
103. Kuliev AM, Modell B, Jackson L, et al. Risk evaluation of CVS. Prenat Diagn 1993; 13: 197.
104. Scott F, Peters H, Boogert T, et al. The loss rates for invasive prenatal testing in specialised obstetric ultrasound practice. Aust N Z J Obstet Gynaecol 2002;42:55.
105. Cohen-Overbeek TE, Hop WC, den Ouden M, et al. Spontaneous abortion rate and advanced maternal age: consequences for prenatal diagnosis. Lancet 1990 ; 336:27.
106. Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003;3:CD003252.
107. Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Lancet 1989;1:1.
108. Smidt-Jensen S, Permin M, Philip J, et al. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet 1992 ; 340:1237.
109. Ammälä P, Hiilesmaa VK, Liukkonen S, et al. Randomized trial comparing first-trimester transcervical chorionic villus sampling and second-trimester amniocentesis. Prenat Diagn 1993;13:919.
110. Borrell A, Fortuny A, Lazaro L, et al. First-trimester transcervical chorionic villus sampling by biopsy forceps versus mid-trimester amniocentesis: a randomized controlled trial project. Prenat Diagn 1999 ; 19:1138.
111. MRC Working Party on the Evaluation of Chorion Villus Sampling. Medical Research Council European trial of chorionic villus sampling. Lancet 1991; 337: 1491.
112. Cederholm M, Axelsson O. A prospective comparative study on transabdominal chorionic villus sampling and amniocentesis performed at 10-13 weeks'gestation. Prenat Diagn 1997;17:311.
113. Nicolaides K, Brizot Mde L, Patel F, et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks'gestation. Lancet 1994;344:435.
114. Sundberg K, Bang J, Smidt-Jensen S, et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997; 350: 697.
115. Nagel HT, Vandenbussche FP, Keirse MJ, et al. Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: a controlled trial with infant follow-up. Prenat Diagn 1998;18:465.
116. Bovicelli L, Rizzo N, Montacuti V, et al. Transabdominal versus transcervical routes for chorionic villus sampling. Lancet 1986;2:290.
117. Smidt-Jensen S, Permin M, Philip J. Sampling success and risk by transabdominal chorionic villus sampling, transcervical chorionic villus sampling and amniocentesis: a randomized study. Ultrasound Obstet Gynecol 1991;1:86.
118. Brambati B, Terzian E, Tognoni G. Randomized clinical trialof transabdominal vs transcervical chorionic villus sampling methods. Prenat Diagn 1991;11:285.
119. Jackson L, Zachary J, Fowler S, et al. A randomised comparison of transcervical and transabdominal chorionic villus sampling. N Engl J Med 1992; 327: 594.
120. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006;108:612.
121. Odibo AO, Dicke JM, Gray DL, et al. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstet Gynecol 2008;112:813.
122. Evans MI, Andriole S. Chorionic villus sampling and amniocentesis in 2008. Curr Opin Obstet Gynecol 2008;20:164.
123. Blakemore K, Filkins K, Luthy D, et al. Cook obstetrics and gynecology catheter multicenter chorionic villus sampling trial: comparison of birth defects with expected rates. Am J Obstet Gynecol 1993;169:1022.
124. Brambati B, Tului L, Guercilena S, et al. Outcome of first-trimester chorionic villus sampling. Obstet Gynecol 2001;17:209.
125. Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. Br J Obstet Gynaecol 2005;112:394.
126. Firth HV, Boyd PA, Chamberlain P, et al. Severe limb abnormalities after chorion villus sampling at 56-66 days'gestation. Lancet 1991; 337: 762.
127. Schloo R, Miny P, Holzgreve W, et al. Distal limb defi-ciency following chorionic villus sampling? Am J Med Genet 1992;42:404.
128. Burton BK, Schultz CJ, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992;79:726.
129. Jahoda MG, Brandenburg H, Cohen-Overbeek T, et al. Terminal transverse limb defects and early chorionic villus sampling: evaluation of 4,300 cases with completed follow-up. Am J Med Genet 1993;46:483.
130. Olney RS, Khoury MJ, Alo CJ, et al. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate Case-Control Study, 1988-1992. Teratology 1995;51:20.
131. Mahoney MJ. Limb abnormalities and chorionic villus sampling. Lancet 1992;337:1422.
132. Monni G, Ibba RM, Lai R, et al. Limb reduction defects and chorionic villus sampling. Lancet 1991; 337: 1091.
133. Ibba RM, Monni G, Lai R, et al. Total fetal malformations following chorion villus sampling. Prenat Diagn 1992;12 :S98.
134. Jackson LG, Wapner RJ, Brambati B. Limb abnormalities and chorionic villus sampling. Lancet 1991; 337: 1423.
135. Kuliev A, Jackson L, Froster U, et al. Chorionic villus sampling safe. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, May 21, 1994. Am J Obstet Gynecol 1996;174:807.
136. Froster-Iskenius UG, Baird PA. Limb reduction defects in over one million consecutive livebirths. Teratology 1989;39:127.
137. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry, 1992-94. Lancet 1996;347:489.
138. Brambati B, Simoni G, Travi M, et al. Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn 1992;12:789.
139. Olney RS, Khoury MJ, Botto LD, et al. Limb defects and gestational age at chorionic villus sampling. Lancet 1994;344:476.
140. Kuliev AM, Modell B, Jackson L, et al. Chorionic villus sampling (CVS): World Health Organization European Regional Office (WHO/EURO) meeting statement on the use of CVS in prenatal diagnosis. J Assist Reprod Genet 1992;9:299.
141. WHO/PAHO consultation on CVS. Evaluation of chorionic villus sampling safety. Prenat Diagn 1999;19:97.
142. Zoppini C, Ludomirsky A, Godmilow L, et al. Acute hemodynamic effects induced by chorionic villus sampling: a preliminary investigation. Am J Obstet Gynecol 1993;169:902.
143. Hibbard JU, Loy GL, Hibbard MC. Does chorionic villus sampling compromise fetal umbilical blood flow? Prenat Diagn 1994;14:1107.
144. Ibba RM, Monni G, Olla G, et al. Umbilical artery velocity waveforms before and after chorionic villus sampling. Prenat Diagn 1994;14:799.
145. Martinez JM, Comas C, Ojuel J, et al. Immediate changes in umbilical blood flow after transcervical chorionic villus sampling performed by biopsy forceps. Prenat Diagn 1996;16:223.
146. Rizzo G, Capponi A. Effects of chorionic villus sampling on placental hemodynamic assessed by three-dimensional power Doppler ultrasonography. Prenat Diagn 2007;27:581.
147. Cederholm M, Haglund B, Axelsson O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. Br J Obstet Gynaecol 2003;110:392.
148. Adusumalli J, Han CS, Beckham S, et al. Chorionic villus sampling and risk for hypertensive disorders of pregnancy. Am J Obstet Gynecol 2007;196:591.
149. Silverman NS, Sullivan MW, Jungkind DL, et al. Incidence of bacteremia associated with chorionic villus sampling. Obstet Gynecol 1994;84:1021
150. Ledbetter DH, Zachary JM, Simpson JL, et al. Cytogenetic results from the U.S. Collaborative Study on CVS. Prenat Diagn 1992;12:317.
151. Cheung SW, Crane JP, Beaver HA, et al. Chromosome mosaicism and maternal cell contamination in chorionic villi. Prenat Diagn 1987;7:535.
152. Grati FR, Grimi B, Frascoli G, et al. Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi. Eur J Hum Genet 2006; 14: 282.
153. Simoni G, Sirchia SM. Confined placental mosaicism. Prenat Diagn 1994;14:1185.
154. Kalousek DK, Dill FJ. Chromosomal mosaicism confined to the placenta in human conceptions. Science 1983;221:665.
155. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996;33:529.
156. d'Alton ME, de Cherney AH. Prenatal diagnosis. N Engl J Med 1993;328:114.